Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampridine with Motor Training in MS
NCT02146534Phase 4Completed
- Sponsor
- Clinique Neuro-Outaouais
- Start
- Dec 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dalfampridine in multiple sclerosis (MS), sponsored by Clinique Neuro-Outaouais. Started Dec 2013; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02146534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02146534.